Barbara Jereczek-Fossa to Treatment Outcome
This is a "connection" page, showing publications Barbara Jereczek-Fossa has written about Treatment Outcome.
Connection Strength
0.224
-
Stereotactic body radiation therapy for mediastinal lymph node metastases: how do we fly in a 'no-fly zone'? Acta Oncol. 2018 Nov; 57(11):1532-1539.
Score: 0.028
-
Nutritional Intervention for Nonsurgical Head and Neck Cancer Patients Treated with Radiation Therapy: Results from a Prospective Stepped-Wedge Clinical Protocol. Nutr Cancer. 2018 10; 70(7):1051-1059.
Score: 0.028
-
Late toxicity of image-guided hypofractionated radiotherapy for prostate: non-randomized comparison with conventional fractionation. Radiol Med. 2019 Jan; 124(1):65-78.
Score: 0.028
-
Ablative stereotactic radiotherapy for oligometastatic colorectal cancer: Systematic review. Crit Rev Oncol Hematol. 2018 Sep; 129:91-101.
Score: 0.028
-
"Give me five" ultra-hypofractionated radiotherapy for localized prostate cancer: non-invasive ablative approach. Med Oncol. 2018 May 10; 35(6):96.
Score: 0.027
-
Stereotactic Body Radiation Therapy for Oligometastatic Ovarian Cancer: A Step Toward a Drug Holiday. Int J Radiat Oncol Biol Phys. 2018 07 01; 101(3):650-660.
Score: 0.027
-
Salvage Stereotactic Body Radiotherapy for Isolated Lymph Node Recurrent Prostate Cancer: Single Institution Series of 94 Consecutive Patients and 124 Lymph Nodes. Clin Genitourin Cancer. 2017 08; 15(4):e623-e632.
Score: 0.025
-
Stereotactic ablative radiation therapy in renal cell carcinoma: From oligometastatic to localized disease. Crit Rev Oncol Hematol. 2017 Sep; 117:48-56.
Score: 0.006
-
Comparison of Treatment Outcome Between Invasive Lobular and Ductal Carcinomas in Patients Receiving Partial Breast Irradiation With Intraoperative Electrons. Int J Radiat Oncol Biol Phys. 2017 09 01; 99(1):173-181.
Score: 0.006
-
Interim 18F-FDG PET/CT During Chemoradiation Therapy in the Management of Head and Neck Cancer Patients: A Systematic Review. Int J Radiat Oncol Biol Phys. 2017 07 01; 98(3):555-573.
Score: 0.006
-
High-Risk Prostate Cancer and Radiotherapy: The Past and the Future. A Benchmark for a New Mixed Beam Radiotherapy Approach. Clin Genitourin Cancer. 2017 06; 15(3):376-383.
Score: 0.006
-
Phase II multi-institutional clinical trial on a new mixed beam RT scheme of IMRT on pelvis combined with a carbon ion boost for high-risk prostate cancer patients. Tumori. 2017 May 12; 103(3):314-318.
Score: 0.006